Insmed
INSM
#961
Rank
A$36.35 B
Marketcap
A$165.70
Share price
5.19%
Change (1 day)
-43.89%
Change (1 year)

Insmed (INSM) - Total debt

Total debt on the balance sheet as of September 2026 : A$0.84 Billion

According to Insmed's latest financial reports the company's total debt is A$0.84 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Insmed - Total debt on balance sheet (from 2005 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$0.87 B-52.58%
2024-12-31A$1.84 B4.52%
2023-12-31A$1.76 B2.1%
2022-12-31A$1.73 B104.95%
2021-12-31A$0.84 B60.4%
2020-12-31A$0.52 B-7.16%
2019-12-31A$0.56 B26.2%
2018-12-31A$0.44 B531.33%
2017-12-31A$71.17 M-6.36%
2016-12-31A$76.01 M120.26%
2015-12-31A$34.5 M13.63%
2014-12-31A$30.37 M37.62%
2013-12-31A$22.06 M18.29%
2012-12-31A$18.65 M6731.99%
2011-12-31A$0.27 M69.14%
2010-12-31A$0.16 M-30.27%
2009-12-31A$0.23 M-92.23%
2008-12-31A$2.97 M-22.8%
2007-12-31A$3.85 M-3.76%
2006-12-31A$4 M-54.42%
2005-12-31A$8.79 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
A$69.97 B 8,162.29%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
A$38.01 B 4,388.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$2.86 B 238.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$1.51 B 78.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A$0.48 B-42.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$1.09 B 28.76%๐Ÿ‡บ๐Ÿ‡ธ USA